Parkinson's Disease Trial, Recruiting (NCT07257861)

Parkinson's Disease Trial, Recruiting NCT07257861 Sponsor: Centre Hospitalier Régional d'Orléans Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07257861 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You (or a trusted family member or relative on your behalf, if you are unable to consent yourself) have agreed to take part in the study
You are an adult of legal age
You have been diagnosed with advanced Parkinson's disease and your doctors have recommended an apomorphine pump as a treatment option
You are receiving home hospitalisation (care at home) for palliative/comfort-focused reasons
You are no longer able to take medication by mouth, and oral treatments have been stopped
Your Parkinson's symptoms when "off" medication are at the most severe level (meaning you have significant difficulties with movement and balance on both sides of your body when your medication is not working) (confirm with trial site)

Who may not be able to join:

You are already using an apomorphine pump
You are opposed to having an apomorphine pump introduced
You are under legal guardianship or a similar form of legal protection
You are currently under court-ordered legal protection
You are currently detained or deprived of your liberty
You are not enrolled in a social security or health insurance scheme
You are currently pregnant or breastfeeding

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 02 38 51 48 86

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07257861

Sponsor: Centre Hospitalier Régional d'Orléans

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: 02 38 51 48 86

More information: https://clinicaltrials.gov/study/NCT07257861

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You (or a trusted family member or relative on your behalf, if you are unable to consent yourself) have agreed to take part in the study
You are an adult of legal age
You have been diagnosed with advanced Parkinson's disease and your doctors have recommended an apomorphine pump as a treatment option
You are receiving home hospitalisation (care at home) for palliative/comfort-focused reasons
You are no longer able to take medication by mouth, and oral treatments have been stopped
Your Parkinson's symptoms when "off" medication are at the most severe level (meaning you have significant difficulties with movement and balance on both sides of your body when your medication is not working) (confirm with trial site)

Who may not be able to join:

You are already using an apomorphine pump
You are opposed to having an apomorphine pump introduced
You are under legal guardianship or a similar form of legal protection
You are currently under court-ordered legal protection
You are currently detained or deprived of your liberty
You are not enrolled in a social security or health insurance scheme
You are currently pregnant or breastfeeding

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre Hospitalier Régional d'Orléans

Registry

ClinicalTrials.gov

Start date

2 February 2026

Est. completion

1 February 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Rigidity; Rigidity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov